Dallmann’s acquires Bübchen from Galderma
Premium
8 May 2020
Dallmann’s Pharma has acquired the German children’s skincare brand Bübchen from Galderma for an undisclosed sum.
Industry News - Tag: Galderma
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Dallmann’s acquires Bübchen from Galderma
All change at Nestlé Skin Health after takeover
Premium
7 October 2019
Nestlé Skin Health has reverted to its original name of Galderma and gained a new team following the recent takeover by a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
Nestlé completes sale of Skin Health to private equity
Premium
4 October 2019
Nestlé has completed the sale of its Skin Health business for CHF10.2 billion (USD10.2 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
Nestlé in exclusive negotiations on Skin Health
16 May 2019
Nestlé has entered into exclusive negotiations on the sale of its Skin Health business for CHF10.2 billion (USD10.1 billion) to a consortium led by private-equity firm EQT and the Abu Dhabi Investment Authority (ADIA).
Galderma seeks GSL switch for Acnecide in UK
10 May 2019
Galderma is seeking to switch two medicines containing benzoyl peroxide – Acnecide Face Gel and Acnecide Face Wash – from pharmacy (P) to general-sale list (GSL) status in the UK.
Nestlé close to completing Skin Health review
Premium
24 April 2019
Nestlé expects to complete the strategic review of its Skin Health business in "mid-2019".
Nestlé sees "strong interest" in Skin Health
Premium
18 February 2019
The strategic review of Nestlé Skin Health has attracted "very strong interest", with people lining up to be part of the process, according to Nestlé's chief executive officer Mark Schneider.
Nestlé Skin Health opens office in Malaysia
25 January 2019
Nestlé Skin Health has opened an office in Malaysia, as media reports suggest a number of private-equity firms are interested in making a bid for the business.